The state's top public health official weighs in on turmoil at the CDC
"I worry that the person who comes next may not have the same scientific principles,," says Massachusetts Public Health Commissioner Dr. Robbie Goldstein.
-
State public health official warns about rise in seasonal illnesses
"This is about the time of year when we would expect to see an increase in COVID, flu, RSV, and also norovirus," said Robbie Goldstein, commissioner of the Massachusetts Department of Public Health. -
New report shows breast and prostate cancer lead Mass. cases
A new report from the American Cancer Society shows that cancer mortality rates continue to decline, but diagnoses are on the rise. -
Need health insurance for 2025? You’ve got 10 days.
Massachusetts residents who don’t have health or dental insurance have until Jan. 23 to sign up for the state Health Connector program. -
Advocates cheer new credit reporting rule, but want more action on medical debt
One in eight or 12.8% of Massachusetts residents reported that their family had medical debt in a 2023 report by the Center for Health Information and Analysis. -
With virus cases surging, Boston hospitals adopt more strict masking policies
Hospitals are once again requiring healthcare staff to wear masks when interacting with patients, and are encouraging patients to mask, as well. -
How removing unpaid medical bills from credit reports could help consumers
The rule is set to take effect in about 60 days, though its fate under the incoming Trump administration is unclear. -
Women in Biotech: Why women in leadership make a difference
"Female leaders bring a different perspective all along the way," one CEO said. -
How do GLP-1 drugs work for weight loss?
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame themselves for it. -
Why are norovirus cases so high right now?
The numbers have significantly changed — but so has the testing technology. -
Study shows gender-affirming drugs are rarely prescribed to adolescents
A study by Harvard Chan School researches shows puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse adolescents, countering concerns among policymakers about over-prescribed drugs to children.